Dongwha Pharm.Co.Ltd - Asset Resilience Ratio

Latest as of December 2025: 1.72%

Dongwha Pharm.Co.Ltd (000020) has an Asset Resilience Ratio of 1.72% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 000020 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩11.07 Billion

≈ $7.50 Million USD Cash + Short-term Investments

Total Assets

₩642.17 Billion

≈ $435.19 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Dongwha Pharm.Co.Ltd's Asset Resilience Ratio has changed over time. See net assets of Dongwha Pharm.Co.Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Dongwha Pharm.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Dongwha Pharm.Co.Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩11.07 Billion	1.72%
Total Liquid Assets	₩11.07 Billion	1.72%

Asset Resilience Insights

Limited Liquidity: Dongwha Pharm.Co.Ltd maintains only 1.72% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Dongwha Pharm.Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Dongwha Pharm.Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Dongwha Pharm.Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.72%	₩11.07 Billion ≈ $7.50 Million	₩642.17 Billion ≈ $435.19 Million	-1.16pp
2024-12-31	2.88%	₩17.84 Billion ≈ $12.09 Million	₩619.63 Billion ≈ $419.92 Million	-0.04pp
2023-12-31	2.92%	₩16.51 Billion ≈ $11.19 Million	₩564.97 Billion ≈ $382.87 Million	-12.98pp
2022-12-31	15.91%	₩73.35 Billion ≈ $49.71 Million	₩461.14 Billion ≈ $312.51 Million	+2.28pp
2021-12-31	13.63%	₩61.03 Billion ≈ $41.36 Million	₩447.80 Billion ≈ $303.47 Million	-0.60pp
2020-12-31	14.23%	₩61.73 Billion ≈ $41.84 Million	₩433.81 Billion ≈ $293.99 Million	-7.64pp
2019-12-31	21.87%	₩82.24 Billion ≈ $55.73 Million	₩376.03 Billion ≈ $254.83 Million	+4.85pp
2018-12-31	17.02%	₩63.07 Billion ≈ $42.74 Million	₩370.60 Billion ≈ $251.15 Million	-9.69pp
2017-12-31	26.71%	₩98.09 Billion ≈ $66.48 Million	₩367.23 Billion ≈ $248.86 Million	+17.16pp
2016-12-31	9.56%	₩31.02 Billion ≈ $21.02 Million	₩324.60 Billion ≈ $219.98 Million	+7.66pp
2015-12-31	1.90%	₩6.02 Billion ≈ $4.08 Million	₩317.19 Billion ≈ $214.95 Million	+0.93pp
2014-12-31	0.96%	₩3.02 Billion ≈ $2.05 Million	₩313.07 Billion ≈ $212.17 Million	+0.01pp
2013-12-31	0.96%	₩3.02 Billion ≈ $2.05 Million	₩316.17 Billion ≈ $214.26 Million	-3.98pp
2012-12-31	4.94%	₩16.02 Billion ≈ $10.86 Million	₩324.28 Billion ≈ $219.76 Million	+4.37pp
2011-12-31	0.57%	₩1.92 Billion ≈ $1.30 Million	₩339.43 Billion ≈ $230.03 Million	--

pp = percentage points

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$113.83 Million

₩167.97 Billion KRW

Market Cap Rank

#18692 Global

#968 in Korea

Share Price

₩6060.00

Change (1 day)

-0.49%

52-Week Range

₩5660.00 - ₩7060.00

All Time High

₩28554.43